SCHEMBL4633241

SCHEMBL4633241

OCCOC(F)(F)C(F)F

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3155618 0.83
SCHEMBL15088608 0.82 TSHR (0.30) TSHRMAPK1
SCHEMBL11897884 0.81
SCHEMBL32678570 0.80 ALDH1A1 (0.32) TSHR
SCHEMBL32678571 0.80 ALDH1A1 (0.32) TSHR
SCHEMBL32678569 0.80 ALDH1A1 (0.32) TSHR
SCHEMBL12269540 0.78
SCHEMBL21069189 0.78
SCHEMBL10594281 0.76
SCHEMBL13613418 0.75 KDM4E (0.30) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026042425-A1 COMPOSITION FOR ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY ダイキン工業株式会社 2026-02-26 WO claimed
WO-2026042425-A1 COMPOSITION FOR ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY ダイキン工業株式会社 2026-02-26 WO disclosed
US-20260008738-A1 HYDROFLUOROETHER COMPOSITION AND METHOD FOR ITS PREPARATION SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2026-01-08 US disclosed
US-20250388526-A1 PROCESS FOR PRODUCING HYDROFLUOROETHERS SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2025-12-25 US disclosed
EP-4547635-A1 PROCESS FOR PRODUCING HYDROFLUOROETHERS Solvay Specialty Polymers Italy S.p.A. (IT) 2025-05-07 EP disclosed
EP-4547634-A1 HYDROFLUOROETHER COMPOSITION AND METHOD FOR ITS PREPARATION Solvay Specialty Polymers Italy S.p.A. (IT) 2025-05-07 EP disclosed
CN-119451930-A Hydrofluoroether compositions and methods of making the same 索尔维特殊聚合物意大利有限公司 2025-02-14 CN disclosed
WO-2024002860-A1 PROCESS FOR PRODUCING HYDROFLUOROETHERS SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2024-01-04 WO disclosed
WO-2024002859-A1 HYDROFLUOROETHER COMPOSITION AND METHOD FOR ITS PREPARATION SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2024-01-04 WO disclosed
US-20200194786-A1 SYSTEM FOR AN IONIC LIQUID-BASED ELECTROLYTE FOR HIGH ENERGY BATTERY Cuberg Inc. 2020-06-18 US disclosed
CN-102701919-B Method for synthesizing fluorine halogenated ether JUHUA GROUP CORP 2014-12-31 CN disclosed
CN-102701919-A Method for synthesizing fluorine halogenated ether JUHUA GROUP CORP 2012-10-03 CN disclosed
US-7435844-B2 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2008-10-14 US disclosed
EP-1934215-A1 ISOTOPICALLY SUBSTITUTED IMIDAZOPYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS Nycomed GmbH (DE) 2008-06-25 EP disclosed
EP-1926714-A1 ISOTOPICALLY SUBSTITUTED BENZIMIDAZOLE DERIVATIVES Nycomed GmbH (DE) 2008-06-04 EP disclosed
WO-2007039464-A1 ISOTOPICALLY SUBSTITUTED IMIDAZOPYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS NYCOMED GMBH (DE) 2007-04-12 WO disclosed
WO-2007023135-A1 ISOTOPICALLY SUBSTITUTED BENZIMIDAZOLE DERIVATIVES NYCOMED GMBH (DE) 2007-03-01 WO disclosed
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides DDT, RYR1, TPMT TSHR 3510/4885MAPK1 3052/4885MEN1 2918/4885
US-20260008738-A1 HYDROFLUOROETHER COMPOSITION AND METHOD FOR ITS PREPARATION F12, F3, AFF1 TSHR 701/4885MAPK1 1905/4885MEN1 2246/4885
US-20250388526-A1 PROCESS FOR PRODUCING HYDROFLUOROETHERS ATM, ADH1A, TFEB TSHR 422/4885MAPK1 1626/4885MEN1 4232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.